Christoph Kanneberger

APEX Ventures GmbH (APEX Ventures) is a venture capital firm founded in 2016 by Christoph Kanneberger and Andreas Riegler. The firm is headquartered in Vienna, Austria.

UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland.

Savity Vermögensverwaltung GmbH provides professional asset management services starting from €3,000 with no minimum term. The private company is located in Austria. The Austrian company has received the highest rating in the robo-advisor test conducted by Capital.

LendFlo Ltd. operates as a platform for converting invoice to cash. It specializes in blockchain, ethereum, and SME financing and investment. The company was founded by Christopher Smith, John Smith and Rémi Tuyaerts in 2017 and is headquartered in London, the United Kingdom.

Elucidate GmbH provides FinCrime risk management services. The firm offers a software as a service platform for the standardized quantification, measurement and reporting of FinCrime risk. The company was founded by Shane Riedel and Filipe Garcia and is headquartered in Berlin, Germany.

Lyfegen HealthTech AG is a Swiss software analytics company that provides a value and outcome-based agreement platform for health insurances, pharma, medtech, and hospitals globally. The company is based in Basel, Switzerland. The company's platform supports the negotiation and automated execution of value-based payment models cost-effectively and at scale using real-world data and machine learning. The platform has been implemented by renowned health insurances, hospitals, pharma, and medtech companies to scale value-based payment models for drugs, therapies, and devices, improving access to treatments and patient outcomes. Lyfegen was founded by Michel Mohler, Girisha Fernando, and Nico Julian Mros, with Girisha Fernando serving as the CEO since incorporation.